nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.103	0.141	CbGbCtD
Ifosfamide—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.103	0.141	CbGbCtD
Ifosfamide—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0778	0.107	CbGbCtD
Ifosfamide—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0665	0.0911	CbGbCtD
Ifosfamide—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0456	0.0626	CbGbCtD
Ifosfamide—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0425	0.0582	CbGbCtD
Ifosfamide—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0425	0.0582	CbGbCtD
Ifosfamide—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0384	0.0526	CbGbCtD
Ifosfamide—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0353	0.0484	CbGbCtD
Ifosfamide—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0353	0.0484	CbGbCtD
Ifosfamide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0271	0.0371	CbGbCtD
Ifosfamide—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0267	0.0367	CbGbCtD
Ifosfamide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0183	0.0251	CbGbCtD
Ifosfamide—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0178	0.0244	CbGbCtD
Ifosfamide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0175	0.0239	CbGbCtD
Ifosfamide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0156	0.0213	CbGbCtD
Ifosfamide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00913	0.0125	CbGbCtD
Ifosfamide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00862	0.0118	CbGbCtD
Ifosfamide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00137	CcSEcCtD
Ifosfamide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00137	CcSEcCtD
Ifosfamide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00137	CcSEcCtD
Ifosfamide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00137	CcSEcCtD
Ifosfamide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00137	CcSEcCtD
Ifosfamide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000261	0.00137	CcSEcCtD
Ifosfamide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00137	CcSEcCtD
Ifosfamide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00026	0.00137	CcSEcCtD
Ifosfamide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00026	0.00137	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00136	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00136	CcSEcCtD
Ifosfamide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00136	CcSEcCtD
Ifosfamide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00136	CcSEcCtD
Ifosfamide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00134	CcSEcCtD
Ifosfamide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00134	CcSEcCtD
Ifosfamide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00134	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00133	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.00133	CcSEcCtD
Ifosfamide—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00133	CcSEcCtD
Ifosfamide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00132	CcSEcCtD
Ifosfamide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00132	CcSEcCtD
Ifosfamide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00132	CcSEcCtD
Ifosfamide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00132	CcSEcCtD
Ifosfamide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00131	CcSEcCtD
Ifosfamide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.00131	CcSEcCtD
Ifosfamide—Infection—Formoterol—chronic obstructive pulmonary disease	0.000249	0.00131	CcSEcCtD
Ifosfamide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.0013	CcSEcCtD
Ifosfamide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.0013	CcSEcCtD
Ifosfamide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.0013	CcSEcCtD
Ifosfamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.00129	CcSEcCtD
Ifosfamide—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000246	0.00129	CcSEcCtD
Ifosfamide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00129	CcSEcCtD
Ifosfamide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00129	CcSEcCtD
Ifosfamide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.00129	CcSEcCtD
Ifosfamide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00129	CcSEcCtD
Ifosfamide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00129	CcSEcCtD
Ifosfamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00128	CcSEcCtD
Ifosfamide—Infection—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00128	CcSEcCtD
Ifosfamide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00128	CcSEcCtD
Ifosfamide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00128	CcSEcCtD
Ifosfamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000243	0.00127	CcSEcCtD
Ifosfamide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000241	0.00126	CcSEcCtD
Ifosfamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00024	0.00126	CcSEcCtD
Ifosfamide—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00126	CcSEcCtD
Ifosfamide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00125	CcSEcCtD
Ifosfamide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00124	CcSEcCtD
Ifosfamide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00124	CcSEcCtD
Ifosfamide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00123	CcSEcCtD
Ifosfamide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00123	CcSEcCtD
Ifosfamide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00123	CcSEcCtD
Ifosfamide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00123	CcSEcCtD
Ifosfamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000233	0.00122	CcSEcCtD
Ifosfamide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00122	CcSEcCtD
Ifosfamide—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00122	CcSEcCtD
Ifosfamide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00121	CcSEcCtD
Ifosfamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000229	0.0012	CcSEcCtD
Ifosfamide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.0012	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.0012	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000228	0.0012	CcSEcCtD
Ifosfamide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00118	CcSEcCtD
Ifosfamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00118	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00117	CcSEcCtD
Ifosfamide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00117	CcSEcCtD
Ifosfamide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00117	CcSEcCtD
Ifosfamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00117	CcSEcCtD
Ifosfamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00117	CcSEcCtD
Ifosfamide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00116	CcSEcCtD
Ifosfamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00116	CcSEcCtD
Ifosfamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00022	0.00115	CcSEcCtD
Ifosfamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00115	CcSEcCtD
Ifosfamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000218	0.00114	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00114	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00114	CcSEcCtD
Ifosfamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00113	CcSEcCtD
Ifosfamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00113	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.00113	CcSEcCtD
Ifosfamide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00112	CcSEcCtD
Ifosfamide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00112	CcSEcCtD
Ifosfamide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00112	CcSEcCtD
Ifosfamide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00112	CcSEcCtD
Ifosfamide—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00112	CcSEcCtD
Ifosfamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00112	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000212	0.00111	CcSEcCtD
Ifosfamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000212	0.00111	CcSEcCtD
Ifosfamide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00111	CcSEcCtD
Ifosfamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.0011	CcSEcCtD
Ifosfamide—Pain—Montelukast—chronic obstructive pulmonary disease	0.00021	0.0011	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00021	0.0011	CcSEcCtD
Ifosfamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.0011	CcSEcCtD
Ifosfamide—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00109	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00109	CcSEcCtD
Ifosfamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000208	0.00109	CcSEcCtD
Ifosfamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000207	0.00109	CcSEcCtD
Ifosfamide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.00109	CcSEcCtD
Ifosfamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00108	CcSEcCtD
Ifosfamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00108	CcSEcCtD
Ifosfamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00108	CcSEcCtD
Ifosfamide—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00108	CcSEcCtD
Ifosfamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000205	0.00108	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00108	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00108	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00107	CcSEcCtD
Ifosfamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00107	CcSEcCtD
Ifosfamide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00106	CcSEcCtD
Ifosfamide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00106	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00105	CcSEcCtD
Ifosfamide—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00105	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00105	CcSEcCtD
Ifosfamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000199	0.00104	CcSEcCtD
Ifosfamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.00104	CcSEcCtD
Ifosfamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00104	CcSEcCtD
Ifosfamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00104	CcSEcCtD
Ifosfamide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00104	CcSEcCtD
Ifosfamide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00104	CcSEcCtD
Ifosfamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.00104	CcSEcCtD
Ifosfamide—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000196	0.00103	CcSEcCtD
Ifosfamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000196	0.00103	CcSEcCtD
Ifosfamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000196	0.00103	CcSEcCtD
Ifosfamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.00103	CcSEcCtD
Ifosfamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00102	CcSEcCtD
Ifosfamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00102	CcSEcCtD
Ifosfamide—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00102	CcSEcCtD
Ifosfamide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00102	CcSEcCtD
Ifosfamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00102	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00102	CcSEcCtD
Ifosfamide—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.00101	CcSEcCtD
Ifosfamide—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.001	CcSEcCtD
Ifosfamide—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000191	0.001	CcSEcCtD
Ifosfamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.000987	CcSEcCtD
Ifosfamide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.000982	CcSEcCtD
Ifosfamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.000982	CcSEcCtD
Ifosfamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000185	0.000969	CcSEcCtD
Ifosfamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.000969	CcSEcCtD
Ifosfamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000184	0.000968	CcSEcCtD
Ifosfamide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.000966	CcSEcCtD
Ifosfamide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000958	CcSEcCtD
Ifosfamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000181	0.000949	CcSEcCtD
Ifosfamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.000944	CcSEcCtD
Ifosfamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00018	0.000944	CcSEcCtD
Ifosfamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.00093	CcSEcCtD
Ifosfamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00093	CcSEcCtD
Ifosfamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000176	0.000924	CcSEcCtD
Ifosfamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.000915	CcSEcCtD
Ifosfamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000174	0.000911	CcSEcCtD
Ifosfamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.0009	CcSEcCtD
Ifosfamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000171	0.0009	CcSEcCtD
Ifosfamide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.000896	CcSEcCtD
Ifosfamide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000892	CcSEcCtD
Ifosfamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.000891	CcSEcCtD
Ifosfamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000168	0.000881	CcSEcCtD
Ifosfamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.000879	CcSEcCtD
Ifosfamide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000873	CcSEcCtD
Ifosfamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00087	CcSEcCtD
Ifosfamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00087	CcSEcCtD
Ifosfamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000162	0.000852	CcSEcCtD
Ifosfamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00085	CcSEcCtD
Ifosfamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.000836	CcSEcCtD
Ifosfamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000159	0.000836	CcSEcCtD
Ifosfamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000158	0.000829	CcSEcCtD
Ifosfamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.000829	CcSEcCtD
Ifosfamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.000828	CcSEcCtD
Ifosfamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000158	0.000828	CcSEcCtD
Ifosfamide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000822	CcSEcCtD
Ifosfamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.000821	CcSEcCtD
Ifosfamide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000821	CcSEcCtD
Ifosfamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000819	CcSEcCtD
Ifosfamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000155	0.000812	CcSEcCtD
Ifosfamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000155	0.000811	CcSEcCtD
Ifosfamide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.00081	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000152	0.0008	CcSEcCtD
Ifosfamide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.000797	CcSEcCtD
Ifosfamide—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000795	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000795	CcSEcCtD
Ifosfamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00079	CcSEcCtD
Ifosfamide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000787	CcSEcCtD
Ifosfamide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000784	CcSEcCtD
Ifosfamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000783	CcSEcCtD
Ifosfamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000782	CcSEcCtD
Ifosfamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000149	0.000781	CcSEcCtD
Ifosfamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.000781	CcSEcCtD
Ifosfamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000146	0.000765	CcSEcCtD
Ifosfamide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000756	CcSEcCtD
Ifosfamide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000753	CcSEcCtD
Ifosfamide—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000742	CcSEcCtD
Ifosfamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000738	CcSEcCtD
Ifosfamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.000734	CcSEcCtD
Ifosfamide—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000732	CcSEcCtD
Ifosfamide—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000728	CcSEcCtD
Ifosfamide—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000725	CcSEcCtD
Ifosfamide—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000716	CcSEcCtD
Ifosfamide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000712	CcSEcCtD
Ifosfamide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000712	CcSEcCtD
Ifosfamide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.000689	CcSEcCtD
Ifosfamide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000681	CcSEcCtD
Ifosfamide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000676	CcSEcCtD
Ifosfamide—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000661	CcSEcCtD
Ifosfamide—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000125	0.00157	CbGpPWpGaD
Ifosfamide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000658	CcSEcCtD
Ifosfamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.00155	CbGpPWpGaD
Ifosfamide—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000124	0.00155	CbGpPWpGaD
Ifosfamide—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000124	0.00155	CbGpPWpGaD
Ifosfamide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000651	CcSEcCtD
Ifosfamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.00154	CbGpPWpGaD
Ifosfamide—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000644	CcSEcCtD
Ifosfamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00153	CbGpPWpGaD
Ifosfamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00064	CcSEcCtD
Ifosfamide—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000638	CcSEcCtD
Ifosfamide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000634	CcSEcCtD
Ifosfamide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000634	CcSEcCtD
Ifosfamide—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00012	0.0015	CbGpPWpGaD
Ifosfamide—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000119	0.00148	CbGpPWpGaD
Ifosfamide—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000118	0.00148	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000118	0.00148	CbGpPWpGaD
Ifosfamide—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000118	0.00148	CbGpPWpGaD
Ifosfamide—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000117	0.00146	CbGpPWpGaD
Ifosfamide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000609	CcSEcCtD
Ifosfamide—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000116	0.00144	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000115	0.00144	CbGpPWpGaD
Ifosfamide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000598	CcSEcCtD
Ifosfamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.00141	CbGpPWpGaD
Ifosfamide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000588	CcSEcCtD
Ifosfamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000587	CcSEcCtD
Ifosfamide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000586	CcSEcCtD
Ifosfamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00139	CbGpPWpGaD
Ifosfamide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000583	CcSEcCtD
Ifosfamide—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000111	0.00138	CbGpPWpGaD
Ifosfamide—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000579	CcSEcCtD
Ifosfamide—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00011	0.00138	CbGpPWpGaD
Ifosfamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.00138	CbGpPWpGaD
Ifosfamide—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000109	0.00136	CbGpPWpGaD
Ifosfamide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000572	CcSEcCtD
Ifosfamide—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000109	0.00136	CbGpPWpGaD
Ifosfamide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00057	CcSEcCtD
Ifosfamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000566	CcSEcCtD
Ifosfamide—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000107	0.00134	CbGpPWpGaD
Ifosfamide—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000107	0.00134	CbGpPWpGaD
Ifosfamide—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.00133	CbGpPWpGaD
Ifosfamide—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.00132	CbGpPWpGaD
Ifosfamide—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00131	CbGpPWpGaD
Ifosfamide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000549	CcSEcCtD
Ifosfamide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000548	CcSEcCtD
Ifosfamide—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.0013	CbGpPWpGaD
Ifosfamide—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00129	CbGpPWpGaD
Ifosfamide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00054	CcSEcCtD
Ifosfamide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00054	CcSEcCtD
Ifosfamide—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.00129	CbGpPWpGaD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000536	CcSEcCtD
Ifosfamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000533	CcSEcCtD
Ifosfamide—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.00127	CbGpPWpGaD
Ifosfamide—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000101	0.00127	CbGpPWpGaD
Ifosfamide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00127	CbGpPWpGaD
Ifosfamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00126	CbGpPWpGaD
Ifosfamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.000525	CcSEcCtD
Ifosfamide—Oedema—Prednisone—chronic obstructive pulmonary disease	9.86e-05	0.000518	CcSEcCtD
Ifosfamide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	9.86e-05	0.000518	CcSEcCtD
Ifosfamide—Infection—Prednisone—chronic obstructive pulmonary disease	9.8e-05	0.000514	CcSEcCtD
Ifosfamide—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.7e-05	0.00121	CbGpPWpGaD
Ifosfamide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	9.67e-05	0.000508	CcSEcCtD
Ifosfamide—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	9.61e-05	0.0012	CbGpPWpGaD
Ifosfamide—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.61e-05	0.0012	CbGpPWpGaD
Ifosfamide—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.59e-05	0.0012	CbGpPWpGaD
Ifosfamide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	9.58e-05	0.000503	CcSEcCtD
Ifosfamide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	9.53e-05	0.0005	CcSEcCtD
Ifosfamide—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.4e-05	0.000493	CcSEcCtD
Ifosfamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.13e-05	0.00114	CbGpPWpGaD
Ifosfamide—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.03e-05	0.00113	CbGpPWpGaD
Ifosfamide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.98e-05	0.000472	CcSEcCtD
Ifosfamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.97e-05	0.000471	CcSEcCtD
Ifosfamide—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.91e-05	0.00111	CbGpPWpGaD
Ifosfamide—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.9e-05	0.00111	CbGpPWpGaD
Ifosfamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.85e-05	0.000465	CcSEcCtD
Ifosfamide—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.84e-05	0.00111	CbGpPWpGaD
Ifosfamide—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.78e-05	0.0011	CbGpPWpGaD
Ifosfamide—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.74e-05	0.00109	CbGpPWpGaD
Ifosfamide—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.7e-05	0.00109	CbGpPWpGaD
Ifosfamide—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.58e-05	0.00107	CbGpPWpGaD
Ifosfamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.57e-05	0.00045	CcSEcCtD
Ifosfamide—Rash—Prednisolone—chronic obstructive pulmonary disease	8.55e-05	0.000449	CcSEcCtD
Ifosfamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.55e-05	0.000449	CcSEcCtD
Ifosfamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.000446	CcSEcCtD
Ifosfamide—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	8.43e-05	0.00105	CbGpPWpGaD
Ifosfamide—Constipation—Prednisone—chronic obstructive pulmonary disease	8.43e-05	0.000443	CcSEcCtD
Ifosfamide—CYP2C18—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.4e-05	0.00105	CbGpPWpGaD
Ifosfamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.18e-05	0.00102	CbGpPWpGaD
Ifosfamide—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.18e-05	0.00102	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	8.17e-05	0.00102	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—GC—chronic obstructive pulmonary disease	8.17e-05	0.00102	CbGpPWpGaD
Ifosfamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000427	CcSEcCtD
Ifosfamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.07e-05	0.00101	CbGpPWpGaD
Ifosfamide—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.06e-05	0.00101	CbGpPWpGaD
Ifosfamide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.06e-05	0.000423	CcSEcCtD
Ifosfamide—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.06e-05	0.00101	CbGpPWpGaD
Ifosfamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.06e-05	0.000423	CcSEcCtD
Ifosfamide—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.99e-05	0.000999	CbGpPWpGaD
Ifosfamide—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.95e-05	0.000994	CbGpPWpGaD
Ifosfamide—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.88e-05	0.000986	CbGpPWpGaD
Ifosfamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	7.83e-05	0.000411	CcSEcCtD
Ifosfamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.79e-05	0.000409	CcSEcCtD
Ifosfamide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.79e-05	0.000409	CcSEcCtD
Ifosfamide—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.75e-05	0.000969	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	7.73e-05	0.000966	CbGpPWpGaD
Ifosfamide—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.64e-05	0.000956	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.64e-05	0.000955	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.6e-05	0.00095	CbGpPWpGaD
Ifosfamide—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.58e-05	0.000947	CbGpPWpGaD
Ifosfamide—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.53e-05	0.000942	CbGpPWpGaD
Ifosfamide—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.47e-05	0.000934	CbGpPWpGaD
Ifosfamide—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.43e-05	0.000929	CbGpPWpGaD
Ifosfamide—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.35e-05	0.000919	CbGpPWpGaD
Ifosfamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.26e-05	0.000381	CcSEcCtD
Ifosfamide—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.25e-05	0.000906	CbGpPWpGaD
Ifosfamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.07e-05	0.000371	CcSEcCtD
Ifosfamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.98e-05	0.000366	CcSEcCtD
Ifosfamide—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	6.97e-05	0.000872	CbGpPWpGaD
Ifosfamide—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.92e-05	0.000866	CbGpPWpGaD
Ifosfamide—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.83e-05	0.000854	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.82e-05	0.000853	CbGpPWpGaD
Ifosfamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.75e-05	0.000354	CcSEcCtD
Ifosfamide—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.72e-05	0.000841	CbGpPWpGaD
Ifosfamide—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.63e-05	0.000829	CbGpPWpGaD
Ifosfamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.63e-05	0.000829	CbGpPWpGaD
Ifosfamide—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.56e-05	0.000821	CbGpPWpGaD
Ifosfamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.52e-05	0.000342	CcSEcCtD
Ifosfamide—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.47e-05	0.000809	CbGpPWpGaD
Ifosfamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.27e-05	0.000329	CcSEcCtD
Ifosfamide—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	6.24e-05	0.00078	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.22e-05	0.000777	CbGpPWpGaD
Ifosfamide—Rash—Prednisone—chronic obstructive pulmonary disease	6.22e-05	0.000326	CcSEcCtD
Ifosfamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.21e-05	0.000326	CcSEcCtD
Ifosfamide—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.18e-05	0.000773	CbGpPWpGaD
Ifosfamide—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.13e-05	0.000767	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	6.1e-05	0.000762	CbGpPWpGaD
Ifosfamide—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.09e-05	0.000762	CbGpPWpGaD
Ifosfamide—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.05e-05	0.000756	CbGpPWpGaD
Ifosfamide—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.86e-05	0.000732	CbGpPWpGaD
Ifosfamide—Nausea—Prednisone—chronic obstructive pulmonary disease	5.86e-05	0.000307	CcSEcCtD
Ifosfamide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.83e-05	0.000729	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.83e-05	0.000729	CbGpPWpGaD
Ifosfamide—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.78e-05	0.000722	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.77e-05	0.000721	CbGpPWpGaD
Ifosfamide—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.63e-05	0.000704	CbGpPWpGaD
Ifosfamide—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	5.63e-05	0.000704	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.59e-05	0.000698	CbGpPWpGaD
Ifosfamide—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.56e-05	0.000695	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	5.43e-05	0.000679	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.41e-05	0.000677	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.37e-05	0.000671	CbGpPWpGaD
Ifosfamide—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.34e-05	0.000668	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	5.28e-05	0.00066	CbGpPWpGaD
Ifosfamide—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.27e-05	0.000659	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	5.27e-05	0.000659	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.12e-05	0.00064	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.05e-05	0.000632	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	4.98e-05	0.000623	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.9e-05	0.000612	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.85e-05	0.000606	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.78e-05	0.000598	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	4.71e-05	0.000589	CbGpPWpGaD
Ifosfamide—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.71e-05	0.000589	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.63e-05	0.000579	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.46e-05	0.000558	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—GCLC—chronic obstructive pulmonary disease	4.41e-05	0.000552	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	4.3e-05	0.000537	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.13e-05	0.000517	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.04e-05	0.000506	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.04e-05	0.000505	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CTGF—chronic obstructive pulmonary disease	4.03e-05	0.000504	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	4.02e-05	0.000502	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.99e-05	0.000499	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.93e-05	0.000491	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.9e-05	0.000488	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.76e-05	0.000471	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.74e-05	0.000467	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.72e-05	0.000465	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.71e-05	0.000464	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.66e-05	0.000458	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.65e-05	0.000457	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.52e-05	0.00044	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.5e-05	0.000437	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.47e-05	0.000434	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.47e-05	0.000434	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	3.4e-05	0.000425	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.36e-05	0.00042	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.16e-05	0.000395	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.12e-05	0.00039	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.1e-05	0.000387	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.09e-05	0.000387	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.06e-05	0.000383	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.05e-05	0.000382	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.04e-05	0.00038	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.97e-05	0.000371	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.93e-05	0.000367	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.88e-05	0.00036	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.85e-05	0.000356	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.84e-05	0.000356	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.84e-05	0.000356	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.83e-05	0.000354	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.82e-05	0.000353	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.82e-05	0.000353	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.77e-05	0.000346	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.72e-05	0.00034	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.7e-05	0.000337	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.69e-05	0.000336	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.68e-05	0.000335	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.65e-05	0.000332	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.6e-05	0.000325	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.57e-05	0.000322	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.52e-05	0.000315	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.47e-05	0.000308	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.45e-05	0.000307	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.39e-05	0.000299	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.26e-05	0.000283	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.25e-05	0.000281	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.2e-05	0.000274	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.17e-05	0.000271	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.15e-05	0.000268	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.12e-05	0.000265	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.06e-05	0.000257	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.05e-05	0.000256	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.03e-05	0.000254	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.99e-05	0.000249	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.98e-05	0.000248	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.97e-05	0.000246	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.94e-05	0.000242	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.89e-05	0.000236	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.89e-05	0.000236	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.88e-05	0.000235	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.86e-05	0.000233	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.86e-05	0.000232	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.84e-05	0.00023	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.83e-05	0.000229	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	1.83e-05	0.000229	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.83e-05	0.000228	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.82e-05	0.000228	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.79e-05	0.000224	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.78e-05	0.000223	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	1.75e-05	0.000219	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.74e-05	0.000217	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.73e-05	0.000217	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.71e-05	0.000214	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.7e-05	0.000212	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.68e-05	0.00021	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.66e-05	0.000207	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.64e-05	0.000205	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.64e-05	0.000205	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.54e-05	0.000193	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.53e-05	0.000191	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.52e-05	0.00019	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.51e-05	0.000189	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.5e-05	0.000188	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.5e-05	0.000187	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.5e-05	0.000187	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.49e-05	0.000186	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.47e-05	0.000183	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.4e-05	0.000175	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.39e-05	0.000174	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.38e-05	0.000172	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.37e-05	0.000171	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.36e-05	0.000171	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.33e-05	0.000166	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.3e-05	0.000162	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.29e-05	0.000161	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.27e-05	0.000159	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.26e-05	0.000157	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.22e-05	0.000152	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.18e-05	0.000148	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	1.18e-05	0.000148	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.17e-05	0.000146	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.15e-05	0.000144	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.13e-05	0.000142	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.13e-05	0.000141	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.12e-05	0.00014	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	1.12e-05	0.00014	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.07e-05	0.000134	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.06e-05	0.000132	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.05e-05	0.000131	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.03e-05	0.000129	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1e-05	0.000125	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.98e-06	0.000125	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.86e-06	0.000123	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.63e-06	0.00012	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.13e-06	0.000114	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	9.01e-06	0.000113	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	9e-06	0.000113	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	8.81e-06	0.00011	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	8.62e-06	0.000108	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	8.42e-06	0.000105	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.29e-06	0.000104	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	7.63e-06	9.54e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	7.3e-06	9.12e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.91e-06	8.65e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.82e-06	8.53e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	6.81e-06	8.51e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	6.51e-06	8.14e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.35e-06	7.95e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	6.21e-06	7.76e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.02e-06	7.53e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.94e-06	7.43e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.09e-06	5.12e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.92e-06	4.9e-05	CbGpPWpGaD
